Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
59,027,044
-
Share change
-
-5,923,457
-
Total reported value
-
$266,772,403
-
Put/Call ratio
-
139%
-
Price per share
-
$4.52
-
Number of holders
-
131
-
Value change
-
-$44,846,104
-
Number of buys
-
66
-
Number of sells
-
73
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q1 2021
As of 31 Mar 2021,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,027,044 shares.
The largest 10 holders included
Indaba Capital Management, L.P., BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, ORBIMED ADVISORS LLC, Neuberger Berman Group LLC, VANGUARD GROUP INC, NEEDHAM INVESTMENT MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This page lists
131
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.